Stock Scorecard



Stock Summary for Cooper Companies Inc (COO) - $77.93 as of 11/28/2025 8:55:04 PM EST

Total Score

12 out of 30

Safety Score

56 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for COO

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for COO

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for COO

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for COO

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for COO (56 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 4
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for COO

Calvert VP SRI Mid Cap Portfolio's The Cooper Companies Inc(COO) Holding History 11/30/2025 3:50:00 AM
The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? 11/27/2025 3:00:00 PM
The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? 11/27/2025 10:00:00 AM
CooperCompanies Faces Pressure From Activists And Falling Shares 11/26/2025 7:06:00 AM
Is Cooper Companies Fairly Priced After Medical Device Acquisition and Recent Share Jump? 11/25/2025 4:18:00 AM
Is Cooper Companies Fairly Priced After Medical Device Acquisition and Recent Share Jump? 11/25/2025 12:00:00 AM
An Intrinsic Calculation For The Cooper Companies, Inc. (NASDAQ:COO) Suggests It's 24% Undervalued 11/24/2025 9:11:00 PM
The Cooper Companies, Inc. - Common Stock (Nasdaq:COO) Stock Quote 11/24/2025 7:36:00 PM
Should Browning West's Push for Vision Care Focus Prompt Action From Cooper Companies (COO) Investors? 11/23/2025 4:21:00 PM
Danaher Corporation $DHR Shares Bought by Mufg Securities Americas Inc. 11/23/2025 12:00:00 AM

Financial Details for COO

Company Overview

Ticker COO
Company Name Cooper Companies Inc
Country USA
Description The Cooper Companies, Inc. (COO) is a leading global medical device firm headquartered in San Ramon, California, specializing in advanced contact lens products and comprehensive solutions for women's health. Through its two main divisions, CooperVision and CooperSurgical, the company emphasizes innovation and improved patient outcomes, catering to a diverse range of healthcare needs. With substantial investment in research and development, The Cooper Companies is poised for continued growth and market expansion, presenting an attractive investment proposition within the dynamic medical device sector for institutional investors.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 7/31/2025
Next Earnings Date 12/4/2025

Stock Price History

Last Day Price 77.93
Price 4 Years Ago 104.70
Last Day Price Updated 11/28/2025 8:55:04 PM EST
Last Day Volume 1,398,721
Average Daily Volume 2,550,729
52-Week High 106.63
52-Week Low 61.77
Last Price to 52 Week Low 26.16%

Valuation Measures

Trailing PE 38.21
Industry PE 399.77
Sector PE 89.93
5-Year Average PE 14.24
Free Cash Flow Ratio 123.70
Industry Free Cash Flow Ratio 42.50
Sector Free Cash Flow Ratio 29.09
Current Ratio Most Recent Quarter 2.12
Total Cash Per Share 0.63
Book Value Per Share Most Recent Quarter 42.02
Price to Book Ratio 1.86
Industry Price to Book Ratio 3.55
Sector Price to Book Ratio 33.13
Price to Sales Ratio Twelve Trailing Months 3.84
Industry Price to Sales Ratio Twelve Trailing Months 45.76
Sector Price to Sales Ratio Twelve Trailing Months 16.04
Analyst Buy Ratings 7
Analyst Strong Buy Ratings 5

Share Statistics

Total Shares Outstanding 198,809,000
Market Capitalization 15,493,185,370
Institutional Ownership 105.76%

Dividends

Ex-Dividend Date 7/26/2023
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0075
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.02
Forward Annual Dividend Yield 0.02%
5-Year Dividend Payments Count 8
3-Year Average Dividend Yield 0.02%
5-Year Average Dividend Yield 0.02%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage -7.19%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -5.80%
Annual Earnings Growth 33.34%
Reported EPS 12 Trailing Months 2.04
Reported EPS Past Year 2.98
Reported EPS Prior Year 3.70
Net Income Twelve Trailing Months 407,800,000
Net Income Past Year 392,300,000
Net Income Prior Year 294,200,000
Quarterly Revenue Growth YOY 5.70%
5-Year Revenue Growth 7.98%
Operating Margin Twelve Trailing Months 16.60%

Balance Sheet

Total Cash Most Recent Quarter 124,900,000
Total Cash Past Year 107,600,000
Total Cash Prior Year 120,800,000
Net Cash Position Most Recent Quarter -2,304,600,000
Net Cash Position Past Year -2,440,400,000
Long Term Debt Past Year 2,548,000,000
Long Term Debt Prior Year 2,523,800,000
Total Debt Most Recent Quarter 2,429,500,000
Equity to Debt Ratio Past Year 0.76
Equity to Debt Ratio Most Recent Quarter 0.77
Total Stockholder Equity Past Year 8,083,400,000
Total Stockholder Equity Prior Year 7,550,800,000
Total Stockholder Equity Most Recent Quarter 8,353,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 411,900,000
Free Cash Flow Per Share Twelve Trailing Months 2.07
Free Cash Flow Past Year 288,100,000
Free Cash Flow Prior Year 215,000,000

Options

Put/Call Ratio 0.92
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 1.28
MACD Signal 0.61
20-Day Bollinger Lower Band 65.17
20-Day Bollinger Middle Band 71.23
20-Day Bollinger Upper Band 77.29
Beta 1.06
RSI 72.72
50-Day SMA 78.64
150-Day SMA 88.46
200-Day SMA 87.27

System

Modified 11/28/2025 8:06:42 PM EST